Granted Patent B2

US 12,606,856 · App. 17/636,256 · Granted Apr 21, 2026

Inventors: Adrian Horgan (Paris, FR); Stephen C. Macevicz (Cupertino, CA)

Assignee: DNA SCRIPT

C12P19/34C12Q1/6869

Abstract

Claims (20)

1 . A method of synthesizing a polynucleotide having a predetermined sequence, the method comprising:

(a) providing an initiator attached by a 5′ end to a solid support and having a 3′-terminal nucleotide with a free 3′-hydroxyl;

(b) repeating cycles of

(i) contacting under elongation conditions the initiator or elongated fragments having free 3′-O-hydroxyls with a 3′-O-blocked nucleoside triphosphate and a template-independent DNA polymerase so that the initiator or elongated fragments are elongated by incorporation of a 3′-O-blocked nucleoside triphosphate to form 3′-O-blocked elongated fragments, and

(ii) deblocking the 3′-O-blocked elongated fragments to form elongated fragments having free 3′-hydroxyls, until polynucleotides having the predetermined sequences are formed;

(c) generating double stranded polynucleotides by annealing primers to the 3′-ends of the polynucleotides formed in (b) and extending the primers with a template-dependent polymerase to create reverse complements of the polynucleotides;

(d) providing reaction conditions with a hybridization stringency that dissociate failure sequences among the double stranded polynucleotides; and

(e) digesting strands of the dissociated double stranded polynucleotides.

2 . The method of claim 1 , wherein the primers are annealed to a common primer binding site of the polynucleotides in (c), and wherein the method further comprises cleaving said common primer binding site from undigested double stranded augmented polynucleotides to produce said polynucleotides of the predetermined sequence.

3 . The method of claim 1 , wherein said template-independent DNA polymerase is a terminal deoxynucleotidyltransferase (TdT) variant having an amino acid sequence at least 90 percent identical to an amino acid sequence selected from SEQ ID NO: 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30 or 31, wherein such selected amino acid sequence is subject to two or more mutations listed in Table 1 for its SEQ ID NO; and wherein the TdT variant

(i) is capable of synthesizing a nucleic acid fragment without a template and

(ii) is capable of incorporating a 3′-O-blocked nucleotide onto a free 3′-hydroxyl of a polynucleotide.

4 . The method of claim 1 , wherein said 3′-O-blocked nucleotide comprises a 3′-O-blocking group selected from the group consisting of 3′-O-methyl, 3′-O-(2-nitrobenzyl), 3′-O-allyl, 3′-O-amine, 3′-O-azidomethyl, 3′-O-tert-butoxy ethoxy, 3′-O-(2-cyanoethyl), 3′-O-nitro, and 3′-O-propargyl.

5 . The method of claim 1 , wherein said initiator comprises a cleavable nucleotide or a cleavable linkage at its 3′-end and wherein said polynucleotides having said predetermined sequences are released from said solid support by cleaving the cleavable nucleotide or the cleavable linkage.

6 . The method of claim 1 , wherein said digesting comprises digesting the strands of the dissociated double-stranded augmented polynucleotides with an exonuclease or a nonspecific single-stranded endonuclease.

7 . The method of claim 1 , wherein reagents for synthesizing the polynucleotide are delivered to reaction sites on the solid support using an inkjet droplet generator or by bulk flow over the solid support.

8 . The method of claim 7 , wherein the reaction sites are organized in a spatially addressable array on the solid support.

9 . The method of claim 8 , wherein each of said reaction sites are distinct and non-overlapping with other said reaction sites.

10 . The method of claim 9 , wherein a different polynucleotide is synthesized at each reaction site.

11 . The method of claim 1 , wherein (b) further comprises capping said initiators or elongated fragments that fail to be elongated.

Assignments (2)

Priority Claims (1)

Continuity (1)

References Cited (170)